Levodopa was first used in clinical trials for Parkinson’s disease in 1961, and it eventually became the gold standard for treatment. Today, it’s still the most common medication available for managing symptoms like tremors and stiffness. But “off” periods — when the medication wears off —…

UZ Leuven and KU Leuven, two institutions in Belgium, have introduced NeuroEXPLORER PET into clinical practice. The ultra-high-resolution PET scanner, developed by United Imaging Healthcare, is designed to visualize small, deep brain regions, including those involved in Parkinson’s disease. Within the first…

Throughout my late uncle Brandon’s journey with Parkinson’s disease, my family made sure he kept up with his physical therapy. At one point, we started seeing progress. His balance seemed a little better. His confidence had improved. And he was buying into the process more than he had in…

Neuropacs’ Automated Imaging Differentiation of Parkinsonism (AIDP) software accurately detected brain changes related to Parkinson’s disease across different patient groups, including some who tested negative on standard alpha-synuclein biomarker tests, a new study has found. The software uses a specialized MRI technique called free-water imaging. These new…

When a diagnosis is made, life goes on. You walk out of your doctor’s office in a fog, wondering if this is a nightmare you’re about to wake up from. You slowly wander into the crowded elevator and can barely muster the strength to push the buttons. You somehow manage…